Sunshine Biopharma Inc. (SBFM)
NASDAQ: SBFM
· Real-Time Price · USD
1.49
-0.01 (-0.67%)
At close: Aug 14, 2025, 3:56 PM
1.50
0.67%
After-hours: Aug 14, 2025, 07:27 PM EDT
-0.67% (1D)
| Bid | 1.41 |
| Market Cap | 6.79M |
| Revenue (ttm) | 36.23M |
| Net Income (ttm) | -5.03M |
| EPS (ttm) | -15.02 |
| PE Ratio (ttm) | -0.1 |
| Forward PE | 17.31 |
| Analyst | Buy |
| Ask | 1.55 |
| Volume | 66,446 |
| Avg. Volume (20D) | 117,032 |
| Open | 1.50 |
| Previous Close | 1.50 |
| Day's Range | 1.42 - 1.50 |
| 52-Week Range | 1.17 - 3.90 |
| Beta | 0.24 |
About SBFM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SBFM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SBFM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
+3.2%
Sunshine Biopharma shares are trading higher after...
Unlock content with
Pro Subscription
4 months ago
+8.17%
Sunshine Biopharma shares are trading higher after the company reported a year-over-year increase in FY24 revenue results.
1 month ago · accessnewswire.com
Sunshine Biopharma Launches NIOPEG(R) Into $10 Billion Biologics MarketFORT LAUDERDALE, FL / ACCESS Newswire / July 2, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of th...
3 months ago · accessnewswire.com
Sunshine Biopharma Reports 2025 First Quarter Results, Revenues Up 18% Over Same Period Last YearFORT LAUDERDALE, FL / ACCESS Newswire / May 15, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of th...